Vimarsana
Biggest News Aggregation in the World

Page 49 - Intelligence Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intelligence Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intelligence Platform Today - Breaking & Trending Today

Liquidity building in Europe's single day options market – IMC | News - Vimarsana News

Liquidity building in Europe's single day options market – IMC | News

Recent launches by Eurex targeting the growing market for single day equity index options point to growing liquidity in the European market for the instruments, mirroring developments in the US over the last few years

Source: fow.com
Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma - Vimarsana News

Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma

Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million…

Broadridge eyes wider DLT roll-out after recent repo success | News - Vimarsana News

Broadridge eyes wider DLT roll-out after recent repo success | News

Horacio Barakat, head of Digital Innovation for Capital markets and general manager of the DLT Repo platform at Broadridge, said the fintech aims to apply Distributed Ledger Technology solutions to various financial instruments

Source: fow.com
HKEX plans to stay open during severe weather events | News - Vimarsana News

HKEX plans to stay open during severe weather events | News

Hong Kong Exchanges and Clearing announced on Thursday that the consultation will last for an eight week period, ending on January 26 2024

Source: fow.com
Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma - Vimarsana News

Culmination Bio Raises $10M From Amgen Ventures and Merck Global Health Innovation Fund to Bring Longitudinal Health Data to Biopharma

Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. As a spinoff from Intermountain Health, Culmination Bio maintains exclusive rights to a physical library and cloud-based data lake covering over 40 years of de-identified patient electronic health records and biospecimen data. As the most extensive data lake of its kind, it...